Long-term outcomes in pulmonary arterial hypertension

被引：3
|
作者：
Thenappan, T. [1 ]
Palevsky, H. I. [2 ]
机构：
[1] Univ Chicago, Med Ctr, Dept Med, Cardiol Sect, Chicago, IL 60637 USA
[2] Univ Penn Hlth Syst, Penn Presbyterian Med Ctr, Dept Med, Div Pulm Allergy & Crit Care, Philadelphia, PA USA
来源：
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 2009年 / 63卷
关键词：
INTRAVENOUS EPOPROSTENOL; SURVIVAL; THERAPY; REGISTRY; ANTICOAGULANT; METAANALYSIS; BOSENTAN; TRIALS;
D O I：
10.1111/j.1742-1241.2009.02128.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：42 / 44
页数：3
相关论文
共 50 条
  • [21] Effects of long-term bosentan in children with pulmonary arterial hypertension
    Rosenzweig, EB
    Ivy, DD
    Widlitz, A
    Doran, A
    Claussen, LR
    Yung, D
    Abman, SH
    Morganti, A
    Nguyen, N
    Barst, RJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (04) : 697 - 704
  • [22] Long-term outcome with intravenous iloprost in pulmonary arterial hypertension
    Hoeper, M. M.
    Gall, H.
    Seyfarth, H. J.
    Halank, M.
    Ghofrani, H. A.
    Winkler, J.
    Golpon, H.
    Olsson, K. M.
    Nickel, N.
    Opitz, C.
    Ewert, R.
    EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (01) : 132 - 137
  • [23] Long-term survival in pulmonary arterial hypertension: the REVEAL registry
    Benza, R. L.
    Miller, D. P.
    Barst, R. J.
    Badesch, D. B.
    Frost, A. E.
    McGoon, M. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 : 676 - 676
  • [24] Long-Term Ambrisentan Therapy for the Treatment of Pulmonary Arterial Hypertension
    Oudiz, Ronald J.
    Galie, Nazzareno
    Olschewski, Horst
    Torres, Fernando
    Frost, Adaani
    Ghofrani, Hossein A.
    Badesch, David B.
    McGoon, Michael D.
    McLaughlin, Vallerie V.
    Roecker, Ellen B.
    Harrison, Brooke C.
    Despain, Darrin
    Dufton, Christopher
    Rubin, Lewis J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (21) : 1971 - 1981
  • [25] Pulmonary arterial hypertension: new challenges in long-term survivors
    Guimaraes, Joana
    Castro, Graca
    Goncalves, Lino
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2024, 25 (12) : e333 - e333
  • [26] Long-term safety and efficacy of imatinib in pulmonary arterial hypertension
    Hoeper, Marius
    Barst, Robyn
    Galie, Nazzareno
    Hassoun, Paul
    Morrell, Nicholas
    Peacock, Andrew
    Simonneau, Gerald
    Tapson, Victor
    Torres, Fernando
    Lawrence, David
    Quinn, Deborah
    Ghofrani, Hossein Ardeschir
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [27] Predictors of Long-Term Outcomes in Systemic Sclerosis Associated Pulmonary Arterial Hypertension from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry
    Kolstad, Kathleen
    Li, Shufeng
    Steen, Virginai D.
    Chung, Lorinda
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [28] Predictors of Long-term Outcomes in Patients With Connective Tissue Disease Associated With Pulmonary Arterial Hypertension
    Nakayama, Kazuhiko
    Nakajima, Yasuo
    Tanaka, Rika
    Hirata, Ken-ichi
    Emoto, Noriaki
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2021, 27 (08) : E371 - E377
  • [29] Long-term outcomes of pulmonary arterial hypertension under specific drug therapy in Eisenmenger syndrome
    Hascoet, Sebastien
    Baruteau, Alban-Elouen
    Humbert, Marc
    Simonneau, Gerald
    Jais, Xavier
    Petit, Jerome
    Laux, Daniela
    Sitbon, Olivier
    Lambert, Virginie
    Capderou, Andre
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : 386 - 398
  • [30] Long Term Outcomes Of Pulmonary Arterial Hypertension In Patients Treated With Dasatinib
    Weatherald, J.
    Chaumais, M. -C.
    Savale, L.
    Jais, X.
    Seferian, A.
    Sitbon, O.
    Simonneau, G.
    Guignabert, C.
    Humbert, M.
    Montani, D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
12345